Trudell Medical Limited to Acquire Vyaire Medical RDx Respiratory Diagnostics Business

4DMedical to Acquire contextflow to Expand European AI Lung Imaging Presence

June 10, 2026

Healthcare Services

4DMedical announced an agreement to acquire Austrian AI-based software lung imaging company contextflow. The deal is intended to give 4DMedical an immediate commercial and clinical platform in Europe and expand its portfolio of AI-powered respiratory imaging solutions, including lung cancer screening and thoracic imaging.

Maverix Medical Acquires Cirrus Bio

March 29, 2024

Biotechnology

Maverix Medical, a lung cancer platform backed by Ajax Health, KKR, and Hologic, has acquired Cirrus Bio to form the foundation of a new diagnostics division, Maverix Dx. Cirrus Bio's multiomic diagnostic capabilities and its founders, David Mallery (CEO) and Scott Morris (CSO), will lead Maverix Dx as the platform pursues further diagnostic product development and M&A.

RDi (LDC-backed) Acquires MedDX and Shuttlepac

October 23, 2023

Healthcare Services

LDC-backed RDi has acquired diagnostic sample collection and transport packaging provider MedDX and biological sample packaging specialist Shuttlepac. The add-on purchases broaden RDi’s healthcare kitting and component capabilities, increase supply-chain control and position the business for planned expansion into the United States.

SunMed Acquires Vyaire Medical's Respiratory & Anesthesia Consumables Business

March 28, 2023

Medical Devices

SunMed, a Frazier Healthcare Partners–backed medical-device manufacturer headquartered in Grand Rapids, Michigan, agreed to acquire Vyaire Medical’s respiratory and anesthesia consumables business, a unit that makes airway management and operative-care consumables. The deal—announced March 28, 2023 and completed May 1, 2023—expands SunMed’s product portfolio, manufacturing footprint and global reach; terms were not disclosed.

Fujirebio Acquires ADx NeuroSciences

June 23, 2022

Healthcare Services

Fujirebio, through its wholly owned subsidiary Fujirebio Europe NV, announced the acquisition of ADx NeuroSciences for €40 million. The deal is expected to close in July 2022, subject to customary closing conditions.

Uniphar plc Acquires RRD International

November 24, 2020

Healthcare Services

Uniphar plc, a Dublin-based diversified healthcare services group, has acquired RRD International, a US-based product development and regulatory consulting firm focused on early-stage biopharmaceutical development. The acquisition is intended to expand Uniphar's US Product Access capabilities—including Expanded Access Programs (EAPs)—and RRD will continue to operate autonomously while integrating with Uniphar's Product Access division.